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Infertility being a multifactorial disorder, both genetic and 
environmental factors contribute to the etiology of infertile 
phenotype. Chromosomal anomalies and Y-microdeletion 
are the established genetic risk factors of male infertility. 
Y-haplotypes has been found as risk factor for male 
infertility in certain populations, though in certain others no 
association has been reported, suggesting a population-
specific association of these variations with male infertility. 
In a case-control study, 165 azoo-/oligospermic patients 
and 200 controls were haplotyped for certain Y-haplogroups 
for a possible association with idiopathic male infertility in 
an Indian population. Analysed Y-haplogroups showed no 
association with infertile phenotype. Thus this genetic factor 
is not a risk for infertility in the studied Indian population 
but that does not rule out the possibility of any of them, to 
be a risk in other populations.
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accumulation of a variety of slow mutating binary markers 
such as SNPs. Variation in their relative frequency in 
different populations gives rise to diverse chromosomal 
haplotypes.[5] A few studies have shown an association of 
certain Y-haplogroups with low sperm count and azoospermia 
in certain populations which fortifies the idea that selection 
processes are still active on the Y-chromosome.[1,6]
An association with infertility has also been shown with 
the common SNP C677T of MTHFR gene in an Indian 
case-control study.[7] However, similar case-control 
studies for MTHFR C677T in European population have 
failed to record any correlation with male infertility.[8-10]
Thus the suggested association of the Y-chromosomal 
haplogroups, and/or polymorphisms in MTHFR gene with 
infertility indicates that certain genotypes/haplotypes 
affect fertility in region-specific manner.
The present study is addressed to the possible association 
of certain Y-haplotypes with infertility in the cases from 
eastern part of India. The Y-haplogroups chosen are those 
whose association with infertility has been demonstrated in 
Japanese and Danish populations.[1,6] However, the results 
failed to reveal any association of the haplogroups with 
infertility in the analysed population, though in the same 
cohort of cases and controls, C677T in the MTHFR gene 
had shown a strong association with infertility.
Materials and Methods
Subjects
In a case-control study, 165 patients classified as 
Introduction
The human Y chromosome contains over 60 million 
nucleotides, and act as a genetic determinant of the 
male characteristic features. Though rearrangement or 
sequence variation in these genes is expected to lead to 
impaired spermatogenesis and reduced sperm count,[1,2] 
seldom has a mutation in a single gene been associated 
with nonobstructive male infertility. On the other hand, the 
genetic cause of idiopathic azoospermia and oligospermia 
is predominantly associated with chromosomal aneuploidy, 
rearrangements, and microdeletions in the AZF region 
of the Y-chromosome.[3,4] The lack of inter-chromosomal 
recombination in larger part of the Y-chromosome facilitates 
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idiopathic azoospermic/oligospermic (157 azoospermic 
and 8 severe oligospermic with sperm count less than 
1 million,mL) and 200 fertile control individuals of 
comparable age group (30, SD +3), belonging to same 
geographical region were haplotyped for the binary 
alleles on the Y-chromosome. The cases were referred 
from the outpatient Endocrinology Clinic at the University 
Hospital and an in vitro fertilization (IVF) and a Urology 
Clinic, all in the city of Varanasi, India. Atleast three 
seminal fluid examinations, carried out after 3-4 days of 
sexual abstinence, were performed to ascertain there 
infertility status. Informed consent was obtained from all 
the subjects to carry out molecular analyses. Institutional 
ethical committee approval was obtained.
Y Haplogroup analysis
Genotyping of 4 SNPs and a 12f2 indel marker for 
all the subjects and controls were carried out by PCR-
RFLP method [Figures 1-3]. The SNPs comprising 
different haplogroups were C→G (M9),[11] C→T (92R7),[12] 
A→G→A (SRY1532),[13,14] C→T (RPS4Y).[15] 12f2 deletion 
was genotyped.[16]
Statistical analysis
Statistical analysis was carried out to assess the 
significance level of the distribution of haplogroups 
between the idiopathic azoospermic/oligospermic 
(n=165) and fertile male control population (n=200).
Results
For Y-haplotyping, SNPs M9, 92R7, SRY-1532, 
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Figure 1: A representative illustration of haplotype 
analysis using 12f2 Indel marker. Haplotyping was done 
by PCR.[16] PCR assay generates a 427 bp product from 
chromosomes carrying the Taq I/10 kb allele but this 
product is absent from Taq I/8-kb allele chromosomes. 
An 800 bp amplicon from the SRY region, present in all 
the chromosomes, is amplified as a control. In the above 
agarose gel in pt #55 and pt #58 12f2 is deleted
Figure 3: SRY 1532 (A→G→A) was haplotyped by PCR-
RFLP method.[13,14]167 bp PCR product after digestion 
with Dra III yields 112bp and 55 bp products for the wild 
type A allele and the mutant G allele was not cut by the 
enzyme (c). RPS4Y (C→T) was haplotyped by PCR-
RFLP.[15] 528 bp PCR product was digested with Bsl I 
and after digestion for wild type C allele 234 bp, 154 bp 
and 140 bp products were obtained whereas for mutant 
T allele 388bp and 140 bp products
Figure 2: M9 (C→G) haplotype was detected by PCR-
RFLP.[11] The 340 bp PCR product after digestion with 
Hinf I yields 172 bp, 100 bp and 68 bp product for the 
wild type C allele and 240 bp and 100 bp products for 
mutant G allele (a). 92R7 (C→T) was also haplotyped 
by PCR-RFLP.[12] The 709 bp PCR product was digested 
with Hind III. 709bp, 512 bp and 197bp fragments were 
obtained for the wild type C allele whereas 709 bp 
product for the mutant T allele as it was not cut by the 
enzyme (b)
RPS4Y and the Indel marker (12f2) were analysed. A 
parsimony network illustrating the relationships between 
the analysed haplogroups is shown in Figure 4. The 
haplogroup frequencies observed in azoo-/oligospermic 
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Table 1: Haplogroup (hg) distribution in azoo-/oligospermic 
cases and control population
hg1 (%) hg2 (%) hg3 (%) hg26 (%) hg9 (%) Total
Azoo-/
oligospermic
42(25.5) 42(25.5) 30 (18.2) 30 (18.2) 21 (12.7) 165
Control 
Population
38 (19) 52 (26) 42 (21) 49 (24.5) 19 (9.5) 200
Total 80 94 72 79 40 365
 χ2 = 4.275, Df= 4, P-value>0.05
Figure 4: Phylogenetic tree of SNPs’ and Indel marker 
used in the study and the haplogroup they define
infertile and fertile control men are summarized in 
Table 1. Out of the 6 haplogroup (Hg) markers used, 
only five were present in the studied population, Hg10, 
defined by RPS4Y711 C→T transition, being absent.[17] 
The association data as well as the frequency of alleles 
of different markers between the fertile and the azoo-/
oligospermic subjects were subjected to χ2 statistical 
analysis. The test results revealed no statistically 
significant difference at the 5% level for both the 
groups. Similarly, the analysed haplogroups revealed 
no difference between the case and control samples 
[Table 1]. Also, there was no significant association in the 
distribution of any of the markers (M9, 92R7 and SRY-
1532) with the case or the control populations.
Discussion
Compared with autosomal or mitochondrial DNA, 
the Y-chromosome shows a relatively higher level 
of geographic specificity. In the context of male 
infertility and Y-haplogroup, Hg 26+ shows a risk for 
infertility in a Danish population.[1] In another report, an 
association of Hg4 with low sperm count and infertility 
was found in a Japanese population.[6] However, a 
reassessment of Kuroki’s Hg 4 data along with other Y 
chromosome haplogroups (Hg20, 5, 2) from the same 
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Japanese population did not find any association with 
infertility.[17] Similarly, a study on Italian subpopulations 
of infertile and control individuals initially indicated an 
association with specific haplogroups and idiopathic 
infertile males, but when samples were subdivided 
according to their origins the putative association 
between the two groups disappeared.[18] The present 
report too does not find any haplogroup’s association 
with infertility. Hg26+, which showed association in 
the Danish population, had only a minor presence in 
both groups in the present study. The fact that so far 
only Hg26+ has shown a clear association suggests 
that there is need for exploring more haplogroups in 
more populations, and that a more rigorous analysis 
of multiple haplogroups may be necessary to derive 
meaningful conclusions.
In this paper we have found no association of 
infertility with the Y-chromosome haplogroups in an 
Indian population. Nevertheless, we maintain that such 
association studies need to be extended in their scope 
and in diverse populations to get a better perspective of 
the genotype-environment interaction in this multifactorial 
disorder.
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